Equol Decreases Hot Flashes in Postmenopausal Women: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

다국어 초록 (Multilingual Abstract)

Soy isoflavones may benefit some, but not all, menopausal women, and the ability of the women to produce equol may be the major determinant of effectiveness. We assessed the efficacy of soy isoflavones and equol for alleviating menopausal symptoms, especially vasomotor symptoms, in postmenopausal women who were equol producers and nonproducers by using systematic review and meta-analysis of randomized clinical trials (RCTs). We searched 12 English, Korean, and Chinese language scientific and medical databases. We selected all available RCTs that assessed the effect of equol, either equol itself or soy isoflavone in equol producers, on menopausal symptoms in peri- or postmenopausal women. The primary outcome was the effect on hot flashes. The severity of hot flashes was determined by the scores, and sensitivity and risk of bias analyses were conducted. Other outcomes of the review, but not meta-analysis, included depression and adverse events. Six studies (779 total subjects) met all criteria for the systematic review, 5 of those could be included in the meta-analysis (728 total subjects). Two studies included in the meta-analysis reported no statistically significant benefits of equol; the other three did report significant benefits of equol. Meta-analysis revealed a significant benefit of equol for lowering hot flash scores and revealed a generally low risk of bias. In conclusion, this study found that supplementing equol to equol nonproducers significantly lowered the incidence and/or severity of hot flashes in menopausal women.

참고문헌 (Reference)

1 Thompson JJ, "Why women choose compounded bioidentical hormone therapy: Lessons from a qualitative study of menopausal decision-making" 17 : 97-, 2017

2 Franco OH, "Use of plant-based therapies and menopausal symptoms : A systematic review and meta-analysis" 315 : 2554-2563, 2016

3 Richard A, "Urinary phytoestrogens and depression in perimenopausal US women : NHANES 2005–2008" 156 : 200-205, 2014

4 Bhagwat S, "USDA Database for the Isoflavone Content of Selected Foods Release 2.0 Nutrient Data"

5 Patisaul HB, "The pros and cons of phytoestrogens" 31 : 400-419, 2010

6 Setchell KD, "The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones" 132 : 3577-3584, 2002

7 Higgins JP, "The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials" 343-355, 2011

8 The NAMS 2017 Hormone Therapy Position Statement Advisory Panel, "The 2017 hormone therapy position statement of The North American Menopause Society" 24 : 728-753, 2017

9 Nishimura Y, "S-equol exerts estradiol-Like anorectic action with minimal stimulation of estrogen receptor-alpha in ovariectomized rats" 8 : 281-, 2017

10 Politi MC, "Revisiting the duration of vasomotor symptoms of menopause: A meta-analysis" 23 : 1507-1513, 2008

11 Shin Yih Tsen, "Relative Inhibitions of 5-Lipoxygenase and Myeloperoxidase and Free-Radical Scavenging Activities of Daidzein, Dihydrodaidzein, and Equol" 한국식품영양과학회 19 (19): 543-548, 2016

12 Yoshikata R, "Relationship between equol producer status and metabolic parameters in 743 Japanese women: Equol producer status is associated with antiatherosclerotic conditions in women around menopause and early postmenopause" 24 : 216-224, 2017

13 Liu ZM, "Randomized controlled trial of whole soy and isoflavone daidzein on menopausal symptoms in equol-producing Chinese postmenopausal women" 21 : 653-660, 2014

14 Li L, "Quantitative efficacy of soy isoflavones on menopausal hot flashes" 79 : 593-604, 2015

15 Prentice RL, "Postmenopausal hormone therapy and the risks of coronary heart disease, breast cancer, and stroke" 32 : 419-425, 2014

16 Poluzzi E, "Phytoestrogens in postmenopause: The state of the art from a chemical, pharmacological and regulatory perspective" 21 : 417-436, 2014

17 Raisz LG, "Pathogenesis of osteoporosis: Concepts, conflicts, and prospects" 115 : 3318-3325, 2005

18 Ishiwata N, "New equol supplement for relieving menopausal symptoms: Randomized, placebo-controlled trial of Japanese women" 16 : 141-148, 2009

19 Copas J, "Meta-analysis, funnel plots and sensitivity analysis" 1 : 247-262, 2000

20 Kim C, "Menopause and risk of diabetes in the Diabetes Prevention Program" 18 : 857-868, 2011

21 Higgins JPT, "Measuring inconsistency in meta-analyses" 327 : 557-560, 2003

22 Hodson L, "Lower resting and total energy expenditure in postmenopausal compared with premenopausal women matched for abdominal obesity" 3 : e3-, 2014

23 Davinelli S, "Influence of equol and resveratrol supplementation on health-related quality of life in menopausal women: A randomized, placebo-controlled study" 96 : 77-83, 2017

24 Crawford SL, "Impact of dose, frequency of administration, and equol production on efficacy of isoflavones for menopausal hot flashes: A pilot randomized trial" 20 : 936-945, 2013

25 Nagata C, "Hot flushes and other menopausal symptoms in relation to soy product intake in Japanese women" 2 : 6-12, 1999

26 Herber-Gast G, "Hot flushes and night sweats are associated with coronary heart disease risk in midlife:A longitudinal study" 122 : 1560-1567, 2015

27 Liu P, "Factors associated with menopausal symptoms among middle-aged registered nurses in Beijing" 31 : 119-124, 2015

28 Márcia Constantino Colli, "Evaluation of the Efficacy of Flaxseed Meal and Flaxseed Extract in Reducing Menopausal Symptoms" 한국식품영양과학회 15 (15): 840-845, 2012

29 Savovic´ J, "Evaluation of the Cochrane Collaboration’s tool for assessing the risk of bias in randomized trials : Focus groups, online survey, proposed recommendations and their implementation" 3 : 37-, 2014

30 Setchell KD, "Equol: Pharmacokinetics and biological actions" 140 : 1363s-1368s, 2010

31 Setchell KD, "Equol: History, chemistry, and formation" 140 : 1355s-1362s, 2010

32 Aso T, "Equol improves menopausal symptoms in Japanese women" 140 : 1386s-1389s, 2010

33 Jackson RL, "Emerging evidence of the health benefits of S-equol, an estrogen receptor beta agonist" 69 : 432-448, 2011

34 Chen MN, "Efficacy of phytoestrogens for menopausal symptoms: A meta-analysis and systematic review" 18 : 260-269, 2015

35 James W. Daily, "Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-analysis of Randomized Clinical Trials" 한국식품영양과학회 19 (19): 717-729, 2016

36 Mark Messina, "Efficacy of Soyfoods and Soybean Isoflavone Supplements for Alleviating Menopausal Symptoms Is Positively Related to Initial Hot Flush Frequency" 한국식품영양과학회 6 (6): 1-11, 2003

37 Jou HJ, "Effect of intestinal production of equol on menopausal symptoms in women treated with soy isoflavones" 102 : 44-49, 2008

38 Freeman EW, "Duration of menopausal hot flushes and associated risk factors" 117 : 1095-1104, 2011

39 Shor D, "Does equol production determine soy endocrine effects" 51 : 389-398, 2012

40 Cheng PF, "Do soy isoflavones improve cognitive function in postmenopausal women? A meta-analysis" 22 : 198-206, 2015

41 Abiru Y, "Discovery of an S-equol rich food stinky tofu, a traditional fermented soy product in Taiwan" 63 : 964-970, 2012

42 Vazquez L, "Development and use of a real-time quantitative PCR method for detecting and quantifying equol-producing bacteria in human faecal samples and slurry cultures" 8 : 1155-, 2017

43 Kimira Y, "Comparative activities of the S-enantiomer and racemic forms of equol on bone fragility in ovariectomized mice" 76 : 1018-1021, 2012

44 Kolovou GD, "Body mass index, lipid metabolism and estrogens: Their impact on coronary heart disease" 21 : 3455-3465, 2014

45 Jenks BH, "A pilot study on the effects of S-equol compared to soy isoflavones on menopausal hot flash frequency" 21 : 674-682, 2012

46 Aso T, "A natural S-equol supplement alleviates hot flushes and other menopausal symptoms in equol nonproducing postmenopausal Japanese women" 21 : 92-100, 2012

47 van der Velpen V, "A double-blind, randomized, placebo-controlled crossover trial in postmenopausal women" 100 : 1269-1277, 2014

48 Newton KM, "A cross-sectional study of equol producer status and self-reported vasomotor symptoms" 22 : 489-495, 2015